AGM/EGMAug 3, 2026, 04:13 PM
Artiva Biotherapeutics to Vote on 2024 Equity Plan Increase
AI Summary
Artiva Biotherapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on September 8, 2026. Stockholders will vote on the election of two Class II directors, the ratification of KPMG LLP as the independent registered public accounting firm for 2026, and an amendment to the 2024 Equity Incentive Plan to increase the aggregate number of shares authorized for issuance by 5,097,095. The record date for voting is July 20, 2026.
Key Highlights
- Annual Meeting of Stockholders scheduled for September 8, 2026, at 2:00 p.m. Pacific Time.
- Meeting will be held virtually via live audio webcast at www.proxydocs.com/ARTV.
- Record date for stockholders entitled to vote is July 20, 2026.
- Proposal 1: Elect two Class II directors to serve until the 2029 Annual Meeting.
- Proposal 2: Ratify KPMG LLP as the independent registered public accounting firm for fiscal year 2026.
- Proposal 3: Approve amendment to 2024 Equity Incentive Plan to increase authorized shares by 5,097,095.
- The Board recommends voting "For" all nominees and "For" all proposals.
- Brian Daniels, M.D. serves as an independent, non-executive Chair of the Board.
Price Impact
More from ARTV